Therefore, CBD has great potential as an anticancer drug for HNSCC, not only due to its cytotoxic effect by inducing genotoxic stress, but also because it specifically targeted EGFR terminal mediators by regulating DUSP1 and KLF6 expression. The gene discussed is DUSP1; the disease is head and neck squamous cell carcinoma.